富瑞:下調高鑫零售(6808.HK)目標價至6.1港元 評級“持有”
富瑞發表研究報吿指,在新冠疫情後,食品零售行業進行了大量投資,特別是在社區團購及其他線上業務模式,高鑫零售(6808.HK)將會投資在新的業務模式,因吸引顧客的地方正在減少,未來亦會進一步加強與阿里巴巴(9988.HK)的合作,下調目標價24.7%,由8.1港元降至6.1港元,重申“持有”評級。
富瑞預期,高鑫零售2022-24年銷售增長分別為8%、10%及10%,而公司所推行的新政策將分別佔當中的銷售額8%、15%及22%,2022-24年毛利率將分別下降至25.2%、24.4%和23.7%,料於2022-23年在租金收入將貢獻不少盈利。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.